-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G1GAAJKvpC9K+XCyAvvTePZXr3KV14DDlL8zD3jVfQ/xZ+Ja8jaeqWZgd4YJx9bZ eQTbWNZI6hrgeAja9V3iDw== 0001166810-02-000007.txt : 20020415 0001166810-02-000007.hdr.sgml : 20020415 ACCESSION NUMBER: 0001166810-02-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020301 FILED AS OF DATE: 20020325 COMPANY DATA: COMPANY CONFORMED NAME: MONTICELLO DANIEL J CENTRAL INDEX KEY: 0001009856 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] DIRECTOR STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 4200 RESEARACH FOREST DR CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 7133646100 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ENCHIRA BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0000895677 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043078857 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21130 FILM NUMBER: 02584194 BUSINESS ADDRESS: STREET 1: 4200 RESEARACH FOREST DR CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 2813646142 MAIL ADDRESS: STREET 1: 4200 RESEARCH FOREST DR CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: ENERGY BIOSYSTEMS CORP DATE OF NAME CHANGE: 19940204 4 1 m430102.txt MONTICELLO FORM 4 MARCH 2002 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 1. Name and Address of Reporting Person* Daniel J. Monticello, Ph.D. 4200 Research Forest Drive The Woodlands, Texas 77380 2. Issuer Name and Ticker or Trading Symbol Enchira Biotechnology Corporation ("ENBC") 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Statement for Month/Year March 2002 5. If Amendment, Date of Original (Month/Year) 6. Relationship of Reporting Persons to Issuer (Check all applicable) [X] Director [ ] 10% Owner [X] Officer (give title below) [ ] Other (specify below) Vice President, Research and Development 7. Individual or Joint/Group Filing (Check Applicable Line) [X] Form filed by One Reporting Person [ ] Form filed by More than One Reporting Person
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of 2. Transaction 3. Transaction 4. Securities 5. Amount of 6. Ownership Form: 7. Nature of Security Date Code Acquired (A) Securities Direct (D) or Indirect (Instr. 3) (Month/Day (Instr. 8) or Disposed of (D) Beneficially Indirect (I) Beneficial Year) (Instr. 3, 4 and 5) Owned at End (Instr. 4) Ownership of Month (Instr. 4) (Instr. 3 and 4) --------------- ---------------------- Code V Amount (A) or Price (D) --------------- ---------------------- - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock 3/1/02 P 3,200 A $0.30 D - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock 3/1/02 P 1,000 A $0.29 D - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock 3/1/02 P 1,800 A $0.26 17,381 D - -----------------------------------------------------------------------------------------------------------------------------------
Page 1 of 2 pages
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., Puts, Calls, Warrants, Options, Convertible Securities) 1. Title of 2. Conver- 3. Trans- 4. Trans- 5. Number of Deriv- 6. Date Exer- 7. Title and Amount of Derivative sion or action action ative Securities cisable and Underlying Securities Security Exercise Date Code Acquired (A) or Expiration (Instr. 3 and 4) (Instr. 3) Price (Month/ (Instr. 8) Disposed of (D) Date of Deri- Day/ (Instr. 3, 4 (Month/Day/ vative Year) and 5) Year) ------------ ----------------- ---------------- -------------------------- Date Expira- Amount or Exer- tion Number of Code V (A) (D) cisable Date Title Shares ------------ ----------------- ---------------- -------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - -----------------------------------------------------------------------------------------------------------------------------------
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) (continued) 8. Price 9. Number of 10. Ownership 11. Nature of of Derivative Form: Indirect Derivative Securities Direct (D) Beneficial Security Beneficially or Indirect Ownership (Instr. 5) Owned at (I) (Instr. 4) End of Month (Instr. 4) - ----------------------------------------------------------------------------------------------------------------------------------- - -----------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses: Reminder: Report a separate line for each class of securities beneficially owned. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Date: March 12, 2002 By: /s/ Daniel J. Monticello ------------------------------- Daniel J. Monticello, Ph.D. Page 2 of 2 pages -----END PRIVACY-ENHANCED MESSAGE-----